IWel Health

IWel's latest disposable glucose CGM.

Emerging Research Assesses Risk of , , and

Emerging Research Assesses Risk of COVID-19, Diabetes, and Obesity | CGM News Today New research published in the Endocrine Society journal Endocrine Reviews sheds light on how we may need to reconsider how we care for patients

Can Grip Be Used to Diagnose ?

Can Grip Strength Be Used to Diagnose Type 2 Diabetes? | Glucose CGM Evaluating a patient’s grip strength may help physicians screen patients for type 2 diabetes, according to new research. This study was published in the

Study finds that patients with are more likely to develop pneumonia, inflammatory storm response, and more.

COVID-19: Diabetes Linked to Pnemonia, Inflammation, and More | Glucose CGM A recent study from Wuhan, China found that adults with COVID-19 and diabetes were more likely to develop an inflammatory storm leading to worsening of

Predicts With 95% Accuracy

Artificial Intelligence Predicts Diabetes With 95% Accuracy | Glucose CGM Researchers have recently used machine learning, a type of artificial intelligence, to help predict who is more likely to develop diabetes. These findings

Adding Functional Data Analysis to Continuous Glucose Monitoring ( ) Improves Maternal Glucose Control

Adding Functional Data Analysis to Continuous Glucose Monitoring (CGM) Improves Maternal Glucose Control | Glucose CGM Recent research has found that coupling functional data analysis to continuous glucose monitoring (CGM) technology can help detect variation in blood

Study Finds Use for to be Lower Amongst Minorities

Study Finds Tech Use for Type 1 Diabetes to be Lower Amongst Minorities | Glucose CGM Recent research has found that African American and Hispanic patients with type 1 diabetes face barriers to the use of continuous glucose monitors (CGMs)

Researchers Find Improves More than in Patients

Researchers Find Exercise Improves Heart Function More than Weight Loss in Diabetic Patients | Glucose CGM A research team has recently found that heart function could be significantly improved in patients with type 2 diabetes if they are put on an exercise

Everything you need to know about and .

Everything you Need to Know about Diabetes and Coronavirus | Glucose CGM With the coronavirus making international headlines for the past month, many patients with chronic diseases are wondering what the implications of this

Women who during are more likely to develop , as per new research. ***co

Women Who Smoke During Pregnancy Are More Likely to Develop Diabetes, Study Finds - Glucose CGM Recent research has found that women who smoke while pregnant are at an increased risk of developing diabetes during pregnancy.

IWel Health added a button to help you learn more about them.

Study Finds that Short, Daily Walks May Be Enough to Prevent , via University of Copenhagen and Steno Diabetes Center Copenhagen

Study Finds that Short, Daily Walks May Be Enough to Prevent Diabetes - Glucose CGM Recent research has found that exercising at moderate intensity each day increases levels of a hormone that may lower one’s risk of developing diabetes.

New research links , the most common medication prescribed to patients with type 2 , may also promote healthy aging. This work was carried out by researchers from Salk Institute, Scripps Research, and Weill Cornell Medicine, and was published in Cell Reports.

Metformin, a Diabetes Drug, May Also Promote Healthy Aging - Glucose CGM Despite being the most commonly prescribed drug for type 2 diabetes, metformin’s blood sugar controlling ability is still not fully understood.

IWel Health updated their business hours.

Alarm Settings and Glucose Outcomes

CGM Alarm Settings and Diabetic Glucose Outcomes - Glucose CGM Diabetic adults who use a continuous glucose monitor (CGM) may fare better with a higher glucose threshold for their hypoglycemia alarms, a new study shows.

New Drug Treating Patients With

New Drug Treating Pediatric Patients With Diabetes - Glucose CGM Sanofi recently announced the success of its Phase 3 study using Toujeo to treat adolescents and children aged 6 and older with type 1 diabetes.

Glutalor welcomes its new leader!

Glutalor Medical Names Brian Heald as Chief Executive Officer and Director EXTON, Pa. (PRWEB) September 28, 2018 -- Former Roche Executive Brings 30 Years of Diabetes Care Experience

Glutalor exhibits its Continuous Glucose Monitoring (CGM) products at 2017 American Diabetes Association (ADA

Glutalor Medical to exhibit its iWel Continuous Glucose Monitoring (CGM) product at the annual American Diabetes Association (ADA) meeting to be held at New Orleans, Louisiana in June 2016. Its iWel CG2 CGM device, an improved CGM product, is under filing for European approval.